As of 2024-12-13, the Relative Valuation of Boston Scientific Corp (BSX) is 43.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 90.42 USD, the upside of Boston Scientific Corp based on Relative Valuation is -51.6%.
The range of the Relative Valuation is 39.83 - 47.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.3x - 38.7x | 37.0x |
| Forward P/E multiples | 28.0x - 33.5x | 30.0x |
| Fair Price | 39.83 - 47.71 | 43.78 |
| Upside | -56.0% - -47.2% | -51.6% |
| Date | P/E |
| 2024-12-13 | 74.42 |
| 2024-12-12 | 74.37 |
| 2024-12-11 | 74.48 |
| 2024-12-10 | 74.18 |
| 2024-12-09 | 72.97 |
| 2024-12-06 | 74.08 |
| 2024-12-05 | 74.46 |
| 2024-12-04 | 74.71 |
| 2024-12-03 | 74.41 |
| 2024-12-02 | 74.37 |
| 2024-11-29 | 74.56 |
| 2024-11-27 | 74.64 |
| 2024-11-26 | 74.19 |
| 2024-11-25 | 73.40 |
| 2024-11-22 | 74.02 |
| 2024-11-21 | 75.25 |
| 2024-11-20 | 74.16 |
| 2024-11-19 | 74.29 |
| 2024-11-18 | 74.39 |
| 2024-11-15 | 71.54 |
| 2024-11-14 | 72.04 |
| 2024-11-13 | 73.01 |
| 2024-11-12 | 72.97 |
| 2024-11-11 | 72.77 |
| 2024-11-08 | 72.58 |
| 2024-11-07 | 71.45 |
| 2024-11-06 | 71.09 |
| 2024-11-05 | 70.35 |
| 2024-11-04 | 69.68 |
| 2024-11-01 | 68.77 |
| 2024-10-31 | 69.10 |
| 2024-10-30 | 69.08 |
| 2024-10-29 | 69.55 |
| 2024-10-28 | 69.71 |
| 2024-10-25 | 69.69 |
| 2024-10-24 | 69.99 |
| 2024-10-23 | 71.92 |
| 2024-10-22 | 72.38 |
| 2024-10-21 | 72.42 |
| 2024-10-18 | 72.43 |
| 2024-10-17 | 71.08 |
| 2024-10-16 | 71.55 |
| 2024-10-15 | 71.36 |
| 2024-10-14 | 72.01 |
| 2024-10-11 | 71.64 |
| 2024-10-10 | 70.90 |
| 2024-10-09 | 71.31 |
| 2024-10-08 | 70.60 |
| 2024-10-07 | 69.42 |
| 2024-10-04 | 69.53 |